There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...